Related Experiment Video
Updated: Aug 16, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent
Ulrike Seay1, Daniel Sedding, Stefanie Krick
1University of Giessen Lung Center, Department of Medicine I, Aulweg 123, Room 6-11, D-35392 Giessen, Germany.
Abstract:
Vascular smooth muscle cells (VSMCs) constitute the major cellular component of the vessel tunica media. VSMC proliferation is a key feature in developing vessels and pathological states such as atherosclerosis and restenosis. Transforming growth factor (TGF)-beta is a key regulator of VSMCs, but its effect on VSMC proliferation and apoptosis are controversial. Here, we characterized TGF-beta effects on basal-, serum-, and platelet-derived growth factor-BB-induced primary mouse VSMC proliferation. TGF-beta led to potent growth inhibition of VSMCs isolated from normal mouse aortae without inducing apoptosis. Growth inhibition by TGF-beta was due to G0/G1 arrest. Next, we explored distinct signaling pathways activated by TGF-beta and the effects of pharmacological inhibition of these. TGF-beta led to activation of Smad2/3, p38, p42/44, and c-Jun NH2-terminal kinase (JNK) pathways, assessed by phosphorylation, immunofluorescence, and reporter gene analysis. TGF-beta-dependent growth inhibition was specifically attenuated by pharmacological blockade of the TGF-beta type I receptor (TbetaRI) kinase or p38 mitogen-activated protein kinase pathways, whereas blockade of p42/44 or JNK kinases did not influence the effect of TGF-beta. TbetaRI kinase inhibition blocked all downstream pathways including Smad and p38 phosphorylation. In contrast, p38 inhibition did not alter Smad function, as assessed by translocation or reporter gene expression, but selectively inhibited p38 activity. These results demonstrate that TGF-beta acts as a potent antiproliferative mediator in VSMCs, irrespective of the proliferative stimulus, without inducing apoptotic effects. The anti-proliferative effect of TGF-beta is due to G0/G1 arrest and mediated primarily by the p38 pathway, suggesting that p38 kinase is central to TGF-beta-mediated growth inhibition in primary mouse VSMCs.
Insights
Transforming growth factor-beta (TGF-β) potently inhibits vascular smooth muscle cell (VSMC) proliferation via G0/G1 arrest, without causing apoptosis. The p38 pathway is central to this TGF-β-mediated antiproliferative effect in VSMCs.
Area of Science:
- Vascular biology
- Cell signaling
- Molecular medicine
Background:
- Vascular smooth muscle cells (VSMCs) are crucial for blood vessel structure and function.
- VSMC proliferation contributes to vascular diseases like atherosclerosis and restenosis.
- The role of transforming growth factor-beta (TGF-β) in regulating VSMC proliferation and apoptosis remains debated.
Purpose of the Study:
- To investigate the precise effects of TGF-β on primary mouse VSMC proliferation and apoptosis.
- To elucidate the specific signaling pathways involved in TGF-β-mediated regulation of VSMC growth.
- To determine the key kinase pathways responsible for TGF-β's antiproliferative actions.
Main Methods:
- Primary mouse VSMCs were treated with TGF-β under basal, serum-, or PDGF-BB-stimulated conditions.
- Cell proliferation was assessed, and apoptosis was evaluated.
- Signaling pathway activation (Smad2/3, p38, p42/44, JNK) was analyzed via phosphorylation and reporter gene assays.
- Pharmacological inhibitors of TGF-β type I receptor (TbetaRI) kinase and specific MAP kinases were used.
Main Results:
- TGF-β significantly inhibited VSMC proliferation without inducing apoptosis, causing cell cycle arrest at the G0/G1 phase.
- TGF-β activated Smad2/3, p38, p42/44, and JNK signaling pathways.
- Inhibition of TbetaRI kinase or p38 kinase attenuated TGF-β-induced growth inhibition.
- p38 inhibition selectively blocked TGF-β's antiproliferative effect without affecting Smad signaling.
Conclusions:
- TGF-β acts as a potent antiproliferative agent for VSMCs, irrespective of the growth stimulus, and does not induce apoptosis.
- The antiproliferative effect is mediated by G0/G1 cell cycle arrest.
- The p38 mitogen-activated protein kinase pathway is a critical mediator of TGF-β's growth-inhibitory function in VSMCs.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Hedgehog Signaling Pathway

